DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
21.45B
Market cap21.45B
Price-Earnings ratio
32.29
Price-Earnings ratio32.29
Dividend yield
Dividend yield
Average volume
10.82M
Average volume10.82M
High today
$58.25
High today$58.25
Low today
$54.11
Low today$54.11
Open price
$57.89
Open price$57.89
Volume
10.94M
Volume10.94M
52 Week high
$93.25
52 Week high$93.25
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

With a market cap of 21.45B, DexCom(DXCM) trades at $55.06. The stock has a price-to-earnings ratio of 32.29.

As of 2025-11-08, DexCom(DXCM) stock has fluctuated between $54.11 and $58.25. The current price stands at $55.06, placing the stock +1.8% above today's low and -5.5% off the high.

The DexCom(DXCM)'s current trading volume is 10.94M, compared to an average daily volume of 10.82M.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.

DXCM News

Simply Wall St 5d
Can DexCom’s Upbeat Outlook Offset Sensor Concerns and Scrutiny Over Device Changes?

In the past week, DexCom reported third-quarter results that surpassed expectations, with quarterly sales of US$1.21 billion and net income of US$283.8 million,...

Can DexCom’s Upbeat Outlook Offset Sensor Concerns and Scrutiny Over Device Changes?
TipRanks 5d
DexCom price target lowered to $82 from $94 at Truist

Truist lowered the firm’s price target on DexCom (DXCM) to $82 from $94 and keeps a Buy rating on the shares. The company’s Q3 earnings and revenue beat was mod...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
16.1%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.